Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)Eunae Sandra Cho, Levon M. Khachigian, Hendrik‐Tobias Arkenau et al.|The Lancet|2013Cited by 107